Trial intelligence / Profile preview

Incidence of Acute Laryngeal Injury Following Endotracheal Intubation

NCT03250975Phase 2Active, not recruiting

Sponsor
Vanderbilt University Medical Center
Start
Aug 2017
Primary completion
Dec 2026
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of azithromycin, budesonide in laryngeal injury, sponsored by Vanderbilt University Medical Center. Started Aug 2017; status: active, not recruiting.

02

Drugs

azithromycinbudesonide
03

Conditions

laryngeal injury

Beyond the preview

Go deeper on NCT03250975.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03250975.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call